Form 4 for TECH Bio-Techne
Accepted 2026-08-18 17:14:42 ET · period of report 2026-08-15 · accession 0000914190-26-000122 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-18 17:14 | 2026-08-15 | TECH | Kelderman Kim | CEO, Dir | M - OptEx | $0.00 | +21.5K | 93.6K | +30% | $0 |
| D | 2026-08-18 17:14 | 2026-08-15 | TECH | Kelderman Kim | CEO, Dir | F - Tax | $72.40 | -10.8K | 82.8K | -12% | -$783.4K |
| DM | 2026-08-18 17:14 | 2026-08-15 | TECH | Kelderman Kim | CEO, Dir | M - OptEx | $0.00 | -21.5K | 23.6K | -48% | $0 |
| DM | 2026-08-18 17:14 | 2026-08-15 | TECH | Kelderman Kim | CEO, Dir | D - Sale to Iss | $0.00 | -63.9K | 1,621 | -98% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-15 | M | A | 21,470 | $0.00 | 93,583 | D | — | — | |
| 2 | Common | Common Stock | 2026-08-15 | F | D | 10,821 | $72.40 | 82,762 | D | — | — | |
| 3 | Derivative | Performance Restricted Stock Units | 2026-08-15 | M | D | 554 | $0.00 | 8,319 | D | — · — to — | 554 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F3) On 8/15/2026, the Board of Directors authorized discretionary vesting for 554 performance RSUs. The remainder of the performance RSUs were forfeited. (F3) On 8/15/2026, the Board of Directors authorized discretionary vesting for 554 performance RSUs. The remainder of the performance RSUs were forfeited. |
| 4 | Derivative | Performance Restricted Stock Units | 2026-08-15 | D | D | 8,319 | $0.00 | 0 | D | — · — to — | 8,319 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F3) On 8/15/2026, the Board of Directors authorized discretionary vesting for 554 performance RSUs. The remainder of the performance RSUs were forfeited. (F3) On 8/15/2026, the Board of Directors authorized discretionary vesting for 554 performance RSUs. The remainder of the performance RSUs were forfeited. |
| 5 | Derivative | Performance Stock Options (Right to Buy) | 2026-08-15 | D | D | 22,389 | $0.00 | 1,492 | D | $84.61 · — to 2030-08-15 | 22,389 Common Stock | (F4) On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,492 performance options. The remainder of the performance options were forfeited. |
| 6 | Derivative | Performance Restricted Stock Units | 2026-08-15 | M | D | 588 | $0.00 | 8,835 | D | — · — to — | 588 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F7) On 8/15/2026, the Board of Directors authorized discretionary vesting for 588 performance RSUs. The remainder of the performance RSUs were forfeited. (F7) On 8/15/2026, the Board of Directors authorized discretionary vesting for 588 performance RSUs. The remainder of the performance RSUs were forfeited. |
| 7 | Derivative | Performance Restricted Stock Units | 2026-08-15 | D | D | 8,835 | $0.00 | 0 | D | — · — to — | 8,835 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F7) On 8/15/2026, the Board of Directors authorized discretionary vesting for 588 performance RSUs. The remainder of the performance RSUs were forfeited. (F7) On 8/15/2026, the Board of Directors authorized discretionary vesting for 588 performance RSUs. The remainder of the performance RSUs were forfeited. |
| 8 | Derivative | Performance Stock Options (Right to Buy) | 2026-08-15 | D | D | 24,324 | $0.00 | 1,621 | D | $68.54 · — to 2031-02-01 | 24,324 Common Stock | (F8) On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,621 performance options. The remainder of the performance options were forfeited. |
| 9 | Derivative | Restricted Stock Units | 2026-08-15 | M | D | 8,543 | $0.00 | 8,544 | D | — · — to — | 8,543 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F11) 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. (F11) 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. |
| 10 | Derivative | Restricted Stock Units | 2026-08-15 | M | D | 11,785 | $0.00 | 23,569 | D | — · — to — | 11,785 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F14) 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. (F14) 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. |